# Intuitive Surgical, Inc. (ISRG) FY2024 Annual Balance Sheet

- Company: Intuitive Surgical, Inc. (ISRG)
- Period: As of 2024-12-31
- Filing: FY2024 10-K, filed 2025-01-31, accession number 0001035267-25-000017
- Page: https://plicit.ai/financials/isrg/fy2024-annual-balance-sheet
- Chart image: https://plicit.ai/charts/isrg-fy2024-annual-balance-sheet-sankey.png

## Chart details

Balance sheet as of 2024-12-31. The chart shows assets, liabilities and equity at that date.

- **Assets**: 18,743,200,000 US dollars
- **Current assets**: 7,111,000,000 US dollars
- **Non-current assets**: 11,632,200,000 US dollars
- **Liabilities**: 2,213,600,000 US dollars
- **Current liabilities**: 1,745,300,000 US dollars
- **Non-current liabilities**: 468,300,000 US dollars
- **Equity**: 16,529,600,000 US dollars
- **Noncontrolling interest**: 95,900,000 US dollars. Included in consolidated equity; this amount is not added again.
- **Cash and cash equivalents**: 2,027,400,000 US dollars
- **Short-term investments**: 1,985,900,000 US dollars
- **Inventory**: 1,487,200,000 US dollars
- **Accounts receivable, net of allowances of $30.7 and $27.1 as of December 31, 2024, and 2023, respectively**: 1,225,400,000 US dollars
- **Prepaids and other current assets**: 385,100,000 US dollars
- **Long-term investments**: 4,819,100,000 US dollars
- **Property, plant, and equipment, net**: 4,646,600,000 US dollars
- **Deferred tax assets**: 1,045,100,000 US dollars
- **Intangible and other assets, net**: 773,900,000 US dollars
- **Goodwill**: 347,500,000 US dollars
- **Other accrued liabilities**: 547,500,000 US dollars
- **Accrued compensation and employee benefits**: 535,600,000 US dollars
- **Deferred revenue**: 468,800,000 US dollars
- **Accounts payable**: 193,400,000 US dollars
- **Other long-term liabilities**: 468,300,000 US dollars
- **Additional paid-in capital**: 9,681,300,000 US dollars
- **Retained earnings**: 6,803,300,000 US dollars
- **Common stock, 600.0 shares authorized, $0.001 par value, 356.6 shares and 352.3 shares issued and outstanding as of December 31, 2024, and 2023, respectively**: 400,000 US dollars
- **Preferred stock, 2.5 shares authorized, $0.001 par value, issuable in series; zero shares issued and outstanding as of December 31, 2024, and 2023**: 0 US dollars
- **Noncontrolling interest in joint venture**: 95,900,000 US dollars
- **Accumulated other comprehensive loss**: negative 51,300,000 US dollars
- **Gross equity (calculated)**: 16,580,900,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

### Chart connections

- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.